Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
about
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entryInfluenza A virus neuraminidase limits viral superinfectionEzrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stageStructural Analysis of Major Species Barriers between Humans and Palm Civets for Severe Acute Respiratory Syndrome Coronavirus InfectionsLentivirus display: stable expression of human antibodies on the surface of human cells and virus particlesIdentification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein.Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyA single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.A single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles.Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.Phosphatidylinositol 4-kinase IIIβ is required for severe acute respiratory syndrome coronavirus spike-mediated cell entrySynthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus.Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.Retrovirus entry by endocytosis and cathepsin proteases.Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and InfectionCell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitorsReceptor recognition and cross-species infections of SARS coronavirusDifferent host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion.SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein.A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.Current status on the development of pseudoviruses for enveloped viruses.AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.
P2860
Q24306622-C6B484FB-D07F-413C-A741-70385230B040Q24656050-9FA4B371-79DF-47BF-9C22-1FD2C0CC5E2EQ27335547-8DAE5124-0413-4168-9C25-8AC103D3B939Q27650493-8D63F571-E464-4791-9B61-96FB3E22F25BQ33368648-7BDB099F-DC0E-4E17-B654-4D6C806B3586Q33529338-687D1E5A-96F1-4495-AB0B-D1263DB1E036Q33780455-DAB13DF4-4059-4220-9B0F-D4696D844D44Q33841118-431E2089-157F-4227-BA87-0DC5841D73FAQ33897964-A15169E6-AE0A-41BC-A3DB-19394251B710Q34055469-02DA8AB6-D94E-4B66-9E68-ADC8E2C49AC9Q34469486-59DBA641-1ADD-46FA-8715-D816E60EDF5CQ34545772-5A678F2D-F251-490C-8701-7BF949AC6C7EQ35665893-C52F0FDC-0B1E-46EF-B774-2EFB749DF367Q35868236-1301791A-AF16-48D3-AAEB-4C09B829ED3DQ35914462-740EA883-A3F8-4DC3-893B-406E2DAFCC89Q36363294-A5331940-6BC1-425A-80F5-A1DDD548B9F7Q36395853-6D4783CF-AF54-47D6-A72A-226F68B00413Q36447896-1925BB94-3DF5-4BD0-848E-EB324AA9A133Q36469011-9AD857E7-D578-44D8-AE7F-D2E6253B1CFDQ36520754-42C2E349-E5A7-4DC7-9632-C8FB6C32CD71Q36827306-A5116A07-2060-490B-AA3E-041C54C3B071Q37530294-A4C1C8FC-3E81-415F-9325-C53B03EF5EE8Q37596746-7B175174-956A-40B4-9A5D-4F032CF27C5BQ38133141-17BF033A-4179-4DE7-A27B-5EE6377A4258Q39571113-6E5B008A-B862-4874-B3C3-95A9466A110DQ40019559-6807743F-DA38-42F2-9BD5-9FFE3C3D8062Q40106974-AC304CB7-4012-4C8B-9807-1F2FE2D321EBQ40295821-60E0D1D9-03E8-486F-A70F-FBAF211582ECQ40329154-9AD5B98E-78FD-4AF9-B3F6-4B572C3F46C9Q40341738-90F0BB3C-C856-4A9A-B93D-32E704B4536EQ41126185-9C012984-50BA-4F83-A8FE-0A4E207A0A87Q42212662-75500B61-FCBA-4307-9E43-DE271C9B6D69Q42424192-735F073A-14D3-411B-AF98-A85EA75BA8EFQ42844863-E4314A90-0AC3-4D7C-AD5B-DBED33BC5A9EQ47568014-8E461C3A-0585-4E04-AE3A-47955B44F257Q52430975-DB7C9136-A15A-4958-918D-73E439EAC71C
P2860
Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@en
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@nl
type
label
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@en
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@nl
prefLabel
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@en
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@nl
P2093
P2860
P50
P1433
P1476
Retroviruses pseudotyped with ...... giotensin-converting enzyme 2.
@en
P2093
Hyeryun Choe
James Coderre
Michael J Moore
Natalya Vasilieva
Swee Kee Wong
Tatyana Dorfman
Thomas C Greenough
Zhongchao Han
P2860
P304
10628-10635
P356
10.1128/JVI.78.19.10628-10635.2004
P407
P577
2004-10-01T00:00:00Z